NCT03291080 - Oral Liquid 13-cis-retinoic Acid (13-CRA) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 17, 2018

Primary Completion Date

September 12, 2019

Study Completion Date

September 12, 2019

Conditions

Neuroblastoma

Interventions

DRUG

Liquid 13-Cis Retinoic Acid

DRUG

Extracted capsules 13-CRA

Trial Locations (10)

Bruce Morland, Birmingham

Dr Antony Ng, Bristol

Dr Amos Burke, Cambridge

Mark Brougham, Edinburgh

Dr Martin Elliott, Leeds

Dr Guiseppe Barone, London

Dr Guy Makin, Manchester

Dr Madhumita Dandapani, Nottingham

Kate Wheeler, Oxford

Sucheta Vaidya, Sutton